メインコンテンツにスキップ
ホーム / コンテンツ / オンデマンド・ウェビナー / Considerations for Management of Clinical Trials and Regulatory Filing Strategy in Light of COVID-19

Considerations for Management of Clinical Trials and Regulatory Filing Strategy in Light of COVID-19

Tue, April 28th 2020
録画ウェビナー

COVID-19 has the potential to negatively impact critical activities such as patient recruitment, patient safety and ensuring data integrity. Thus, clinical developers should review their planned regulatory filing strategies to determine if modifications are required. Attend this webinar to learn mitigation strategies and best practices that you can begin implementing now.

Speakers:
Demetrius Carter, SVP Services Operations & Regulatory Services
Elaine B. Taylor, VP, Regulatory Strategy and Policy

Powered by Translations.com GlobalLink OneLink Software